SOSV

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Founded in 2020, SunGreenH2 specializes in developing high-performance electrolysers using nanotechnology and advanced materials. Headquartered in Singapore with offices in Melbourne and London, the company produces green hydrogen at low cost for industries, mobility, and energy storage.

AromatEco assists household brands in becoming more environmentally friendly by delivering renewable flavors and perfumes. Headquartered in London, UK.

LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Kutanios is a biotechnology company headquartered in London. It specializes in developing novel compounds for anti-aging, sun care, anti-acne, and skin cleaning products using its proprietary biodegradable molecules technology.

Kutanios is a biotechnology company headquartered in London. It specializes in developing novel compounds for anti-aging, sun care, anti-acne, and skin cleaning products using its proprietary biodegradable molecules technology.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

SAVA develops advanced biosensing technology for painless, real-time, and affordable health monitoring. Their innovative solutions enable continuous tracking of glucose and lactate levels, empowering users with real-time bodily insights to optimize performance and nutrition.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Founded in 2020, SunGreenH2 specializes in developing high-performance electrolysers using nanotechnology and advanced materials. Headquartered in Singapore with offices in Melbourne and London, the company produces green hydrogen at low cost for industries, mobility, and energy storage.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms, focusing on plant-inspired proteins for commercial applications in the food and beverage industries. One of its notable products is brazzein, a protein sweetener designed to provide a non-caloric alternative for consumers, addressing concerns related to sugar content and associated health issues. Additionally, Magellan Life Sciences is advancing its XSeed platform, which further enhances its capabilities in creating novel protein-based molecules tailored for the food, health, and nutrition sectors.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Arthronica is a company developing an artificial intelligence-based platform for patient monitoring and rehabilitation, with a focus on arthritis and chronic rheumatic conditions. Its technology uses skeletal tracking, image analysis, and video analysis to monitor and predict key disease activities, supporting objective assessments of swelling and movement. The platform incorporates force-sensing vision and 3D CAD modeling to quantify physical changes and track disease progression for patients and practitioners. By enabling continuous monitoring and data-driven rehabilitation, Arthronica aims to improve clinical decision making and patient outcomes in musculoskeletal care. The company has conducted clinical trials in the United Kingdom and United States to validate its algorithms and system for real-world use.

BrightCure Ltd., established in 2019 and based in London, United Kingdom, specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). The company focuses on addressing recurrent and difficult-to-treat bacterial infections, a significant health issue affecting 50% of women and 12% of men globally. BrightCure's approach involves utilizing the natural microbiome to reduce harmful bacteria and replenish beneficial bacteria in the vaginal flora, thereby boosting the immune system to promote urinary tract health. The company has garnered recognition through various competitions and accelerators, including selection for Indiebio, the world's largest biotech accelerator.

BrightCure Ltd., established in 2019 and based in London, United Kingdom, specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). The company focuses on addressing recurrent and difficult-to-treat bacterial infections, a significant health issue affecting 50% of women and 12% of men globally. BrightCure's approach involves utilizing the natural microbiome to reduce harmful bacteria and replenish beneficial bacteria in the vaginal flora, thereby boosting the immune system to promote urinary tract health. The company has garnered recognition through various competitions and accelerators, including selection for Indiebio, the world's largest biotech accelerator.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Breather Products Inc. is a company that specializes in providing on-demand private workspaces designed for productivity. Founded in 2012 and headquartered in Montreal, Canada, Breather has established a network of flexible office spaces available for reservation via its web and mobile applications. The company's offerings allow clients to rent spaces by the hour, day, or month, catering to various business needs. With locations in major cities, including New York, San Francisco, Los Angeles, Boston, Chicago, Washington, Toronto, Montreal, and London, each workspace is equipped with essential technology to facilitate immediate productivity. Breather aims to create comfortable and private environments that enhance operational efficiency for businesses and corporate clients.

Arthronica is a company developing an artificial intelligence-based platform for patient monitoring and rehabilitation, with a focus on arthritis and chronic rheumatic conditions. Its technology uses skeletal tracking, image analysis, and video analysis to monitor and predict key disease activities, supporting objective assessments of swelling and movement. The platform incorporates force-sensing vision and 3D CAD modeling to quantify physical changes and track disease progression for patients and practitioners. By enabling continuous monitoring and data-driven rehabilitation, Arthronica aims to improve clinical decision making and patient outcomes in musculoskeletal care. The company has conducted clinical trials in the United Kingdom and United States to validate its algorithms and system for real-world use.

SAVA develops advanced biosensing technology for painless, real-time, and affordable health monitoring. Their innovative solutions enable continuous tracking of glucose and lactate levels, empowering users with real-time bodily insights to optimize performance and nutrition.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Encelo Laboratories Limited develops and supplies cell isolation tools that enable researchers, clinicians, and pharmaceutical companies to obtain live cells non‑invasively from urine samples. Its flagship product, a cell isolation cup, selectively captures and preserves primary cells for shipment, improving recovery rates compared to conventional methods. The technology supports a range of precision‑medicine applications, including disease diagnostics, drug screening, and regenerative‑medicine research, by providing readily available patient‑specific live cells at scale.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms, focusing on plant-inspired proteins for commercial applications in the food and beverage industries. One of its notable products is brazzein, a protein sweetener designed to provide a non-caloric alternative for consumers, addressing concerns related to sugar content and associated health issues. Additionally, Magellan Life Sciences is advancing its XSeed platform, which further enhances its capabilities in creating novel protein-based molecules tailored for the food, health, and nutrition sectors.

Caura Ltd. is a London-based company that specializes in designing and manufacturing innovative vehicle management solutions. The company's platform facilitates payments for essential car-related expenses, including parking, tolls, congestion charges, MOTs, vehicle tax, and insurance. Caura Protect, an FCA-registered product, enables drivers to purchase and manage motor insurance from multiple insurers. Additionally, Caura Maintain streamlines the management of MOTs and vehicle servicing. Founded in 2018, Caura aims to simplify car ownership by integrating various services into an accessible platform, enhancing the overall experience for drivers.

NeuroCreate is a technology company that develops FlowCreate Innovator, an AI-powered platform that applies neuroscience to enhance cognition, creativity, and workflow. The platform provides digital tools to support strategizing, problem solving, and idea generation, aiming to help users reach a flow state more quickly and sustain high performance. By combining artificial intelligence, neuroscience, and design, NeuroCreate seeks to improve digital health and mental flexibility, offering personalized experiences that promote wellbeing and productivity. The company emphasizes human-centered AI and ethical product design, with a focus on inclusive access to peak cognitive performance. Founded in 2017 and based in London, NeuroCreate positions its solutions as enabling professionals to augment work processes, accelerate learning, and explore creativity through NeuroDesign, a framework that translates neuroscience into practical digital products.

Kokoon Technology Limited, established in 2013 and headquartered in London, specializes in sleep technology. The company manufactures headphones equipped with EEG brainwave sensing technology and movement sensors, enabling precise sleep monitoring. Kokoon's products include active noise cancellation, noise isolation, and active white noise features, along with a mobile app offering a relaxation audio library and personalized sleep analysis. The company aims to make sleep science more accessible and enjoyable, delivering personalized audio coaching and experiences through its app-based software platform.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Kokoon Technology Limited, established in 2013 and headquartered in London, specializes in sleep technology. The company manufactures headphones equipped with EEG brainwave sensing technology and movement sensors, enabling precise sleep monitoring. Kokoon's products include active noise cancellation, noise isolation, and active white noise features, along with a mobile app offering a relaxation audio library and personalized sleep analysis. The company aims to make sleep science more accessible and enjoyable, delivering personalized audio coaching and experiences through its app-based software platform.

Breather Products Inc. is a company that specializes in providing on-demand private workspaces designed for productivity. Founded in 2012 and headquartered in Montreal, Canada, Breather has established a network of flexible office spaces available for reservation via its web and mobile applications. The company's offerings allow clients to rent spaces by the hour, day, or month, catering to various business needs. With locations in major cities, including New York, San Francisco, Los Angeles, Boston, Chicago, Washington, Toronto, Montreal, and London, each workspace is equipped with essential technology to facilitate immediate productivity. Breather aims to create comfortable and private environments that enhance operational efficiency for businesses and corporate clients.

Kokoon Technology Limited, established in 2013 and headquartered in London, specializes in sleep technology. The company manufactures headphones equipped with EEG brainwave sensing technology and movement sensors, enabling precise sleep monitoring. Kokoon's products include active noise cancellation, noise isolation, and active white noise features, along with a mobile app offering a relaxation audio library and personalized sleep analysis. The company aims to make sleep science more accessible and enjoyable, delivering personalized audio coaching and experiences through its app-based software platform.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Sian's Plan makes healthy eating convenient. They're up early, in bed late and in between it's go go go. Throw a couple of kids into the equation and where is the time for healthy food? All of a sudden it becomes very difficult for you to take care of what matters most to you, keeping yourself and your family healthy. Sian's Plan solves this. ✷Target Market✷ Their target market are young professional/busy mums with one or more school going children. They are technology savvy, using the internet daily and spend on average £100 per weekly shop. Young professionals are a secondary market showing organic growth and They intend to expand into this market once resources allow. ✷Key stats✷ ◇ Average time spent by an active member is 4 min on recipes, 4 min on meal planning and 4 min on grocery list per visit. ◇ 5k members if free beta ◇ Beat Yummly to be awarded "Most innovative digital solution for home cooks globally" in 2012. ✷Business model✷ Primary – Subscriptions: Subscribers pay either £4.99/m and £9.99/m. Secondary – Affiliate commission: Supermarkets pay between £5 and £8 per new purchasing sign up and between 25p and £1 per transaction originating from Sian’s Plan. ✷Team✷ Vincent is the hands on CEO described as 'one of London's hottest culinary entreprenuers' by The Guardian. Sian is the expert who embodies the home cook. Fiona brings vast experience in operations and business development from her managerial position in Deloitte. Glyn Britton (Albion London) advises on marketing, Colin Mitchell (ex-CTO Tesco diets) on tech and Sian Porter (spokeswoman for the British Dietetic Association) on nutrition. ✷Market✷ Currently focused on the UK they are perfectly positioned to scale to the US and Australia where current angels are based. The Mama Market is $2.1 Trillion Strong and growing (Forbes). 19.5 million households in the UK alone engage in some sort of menu planning and with 44% of us shopping online for groceries, sales are expected to be £9.6bn by 2015. ✷Latest member review✷ Hi Sian, thank you guys!! You ve really helped me out, with 2 young boys and little culinary imagination it's [Sian's Plan] amazing! Rose, UK. Rose averages 1.47 visits per day over 30 days, signed up to the yearly £9.99 package and in her own words "I have recommended it to a lot of other mums!".

Sian's Plan makes healthy eating convenient. They're up early, in bed late and in between it's go go go. Throw a couple of kids into the equation and where is the time for healthy food? All of a sudden it becomes very difficult for you to take care of what matters most to you, keeping yourself and your family healthy. Sian's Plan solves this. ✷Target Market✷ Their target market are young professional/busy mums with one or more school going children. They are technology savvy, using the internet daily and spend on average £100 per weekly shop. Young professionals are a secondary market showing organic growth and They intend to expand into this market once resources allow. ✷Key stats✷ ◇ Average time spent by an active member is 4 min on recipes, 4 min on meal planning and 4 min on grocery list per visit. ◇ 5k members if free beta ◇ Beat Yummly to be awarded "Most innovative digital solution for home cooks globally" in 2012. ✷Business model✷ Primary – Subscriptions: Subscribers pay either £4.99/m and £9.99/m. Secondary – Affiliate commission: Supermarkets pay between £5 and £8 per new purchasing sign up and between 25p and £1 per transaction originating from Sian’s Plan. ✷Team✷ Vincent is the hands on CEO described as 'one of London's hottest culinary entreprenuers' by The Guardian. Sian is the expert who embodies the home cook. Fiona brings vast experience in operations and business development from her managerial position in Deloitte. Glyn Britton (Albion London) advises on marketing, Colin Mitchell (ex-CTO Tesco diets) on tech and Sian Porter (spokeswoman for the British Dietetic Association) on nutrition. ✷Market✷ Currently focused on the UK they are perfectly positioned to scale to the US and Australia where current angels are based. The Mama Market is $2.1 Trillion Strong and growing (Forbes). 19.5 million households in the UK alone engage in some sort of menu planning and with 44% of us shopping online for groceries, sales are expected to be £9.6bn by 2015. ✷Latest member review✷ Hi Sian, thank you guys!! You ve really helped me out, with 2 young boys and little culinary imagination it's [Sian's Plan] amazing! Rose, UK. Rose averages 1.47 visits per day over 30 days, signed up to the yearly £9.99 package and in her own words "I have recommended it to a lot of other mums!".

Yoyo Wallet, established in 2013 and headquartered in London, specializes in mobile payment solutions. It offers a user-friendly app enabling customers to make in-store purchases using their smartphones, processing over 150,000 monthly transactions. The platform combines payment and loyalty features, providing retailers with a marketing tool for in-store customer engagement and targeted rewards based on purchase history. Yoyo Wallet serves retailers, universities, and corporate locations across the United Kingdom.

Breather Products Inc. is a company that specializes in providing on-demand private workspaces designed for productivity. Founded in 2012 and headquartered in Montreal, Canada, Breather has established a network of flexible office spaces available for reservation via its web and mobile applications. The company's offerings allow clients to rent spaces by the hour, day, or month, catering to various business needs. With locations in major cities, including New York, San Francisco, Los Angeles, Boston, Chicago, Washington, Toronto, Montreal, and London, each workspace is equipped with essential technology to facilitate immediate productivity. Breather aims to create comfortable and private environments that enhance operational efficiency for businesses and corporate clients.

Zartis is a global digital solutions provider specializing in bespoke software development teams. With expertise across various technologies and cloud architectures, they offer services including application development, software architecture, CI/CD, business intelligence, QA automation, and new technology integrations. Zartis partners with diverse industries, delivering innovative tech solutions through their engineering hubs in Ireland, Spain, and Poland.